Outset Medical, Inc. (OM) announced a one-for-fifteen reverse stock split of its common stock, effective March 20, 2025.
Trading will continue under the ticker OM on Nasdaq with a new CUSIP number. Approved by stockholders on March 5, 2025, the split consolidates every 15 pre-split shares into one, reducing outstanding shares from 265 million to approximately 17 million while maintaining the authorized share count and par value.
The split uniformly affects all stockholders, preserving ownership percentages except for fractional shares, which will be compensated in cash. Equity incentive plans, stock options, and warrants will be proportionally adjusted.
Equiniti Trust Company, LLC will manage the process, issuing post-split shares electronically. No action is required from stockholders, as adjustments will be handled automatically by brokers and custodians. Further details are available in Outset Medical's SEC filings.
OM is currently trading at $0.519 or 10.2090% lower on the Nasdaq Global Select Market.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.